Dr Maria Freire

Chief Executive Officer of the Global Alliance for TB Drug Development

Maria Freire

Dr. Maria C. Freire was named Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance) in September 2001. The TB Alliance is a not-for-profit, public-private partnership created to develop new, faster-acting anti-TB medicines that are affordable and accessible to patients world-wide.

An internationally recognized expert in technology commercialization, Dr. Freire directed the Office of Technology Transfer at the U.S. National Institutes of Health (NIH) from 1995 to 2001. While there, she was responsible for the central development and implementation of technology transfer policies and procedures for the Department of Health and Human Services, and for the patenting and licensing activities for the NIH and the Food and Drug Administration. Prior to joining the NIH, Dr. Freire established and headed the Office of Technology Development at the University of Maryland at Baltimore and the University of Maryland, Baltimore County.

Born in Lima, Peru, Dr. Freire trained at the Universidad Peruana Cayetano Heredia in Lima. She received a Ph.D. in Biophysics from the University of Virginia and completed post-graduate work in immunology and virology at the University of Virginia and the University of Tennessee, respectively. She is the recipient of a Fulbright Fellowship as well as two U.S. Congressional Science Fellowships.

Dr. Freire has been active on a number of national and international boards and committees. She is the recipient of numerous awards, including the DHHS Secretary's Award for Distinguished Service, the 1999 Arthur S. Flemming Award and the 2002 Bayh-Dole Award. She has written and spoken extensively about science in the public interest and how society's most advanced technologies can be leveraged for global health priorities.